前列腺小细胞神经内分泌癌1例报告

Q4 Medicine

中华泌尿外科杂志 Pub Date : 2020-01-15 DOI:10.3760/CMA.J.ISSN.1000-6702.2020.01.016

Min Zhang

{"title":"前列腺小细胞神经内分泌癌1例报告","authors":"Min Zhang","doi":"10.3760/CMA.J.ISSN.1000-6702.2020.01.016","DOIUrl":null,"url":null,"abstract":"To study the diagnosis and treatment of small cell neuroendocrine prostatic carcinoma. A 60-year-old patient with pure small cell neuroendocrine carcinoma of prostate was admitted because of dysuria for 1 month. Digital rectal examination showed the prostate was hard. Result of histological biopsy were consistent with a diagnosis of small cell neuroendocrine carcinoma of prostate. Combination chemotherapy with radiotherapy regimen were proved to be effective. The patient′s symptoms were relieved obviously. The patient died about 15 months after admission. Small cell neuroendocrine carcinoma of prostate has a very poor prognosis. Systemic chemotherapy is the most important treatment available. \n \n \nKey words: \nProstatic neoplasms; Small cell neuroendocrine carcinoma; Chemotherapy","PeriodicalId":10343,"journal":{"name":"中华泌尿外科杂志","volume":"41 1","pages":"66-67"},"PeriodicalIF":0.0000,"publicationDate":"2020-01-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"A case report of small cell neuroendocrine carcinoma of prostate\",\"authors\":\"Min Zhang\",\"doi\":\"10.3760/CMA.J.ISSN.1000-6702.2020.01.016\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"To study the diagnosis and treatment of small cell neuroendocrine prostatic carcinoma. A 60-year-old patient with pure small cell neuroendocrine carcinoma of prostate was admitted because of dysuria for 1 month. Digital rectal examination showed the prostate was hard. Result of histological biopsy were consistent with a diagnosis of small cell neuroendocrine carcinoma of prostate. Combination chemotherapy with radiotherapy regimen were proved to be effective. The patient′s symptoms were relieved obviously. The patient died about 15 months after admission. Small cell neuroendocrine carcinoma of prostate has a very poor prognosis. Systemic chemotherapy is the most important treatment available. \\n \\n \\nKey words: \\nProstatic neoplasms; Small cell neuroendocrine carcinoma; Chemotherapy\",\"PeriodicalId\":10343,\"journal\":{\"name\":\"中华泌尿外科杂志\",\"volume\":\"41 1\",\"pages\":\"66-67\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2020-01-15\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"中华泌尿外科杂志\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.3760/CMA.J.ISSN.1000-6702.2020.01.016\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"Medicine\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"中华泌尿外科杂志","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.3760/CMA.J.ISSN.1000-6702.2020.01.016","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Medicine","Score":null,"Total":0}

引用次数: 0

摘要

探讨小细胞神经内分泌前列腺癌的诊断和治疗。一位60岁的前列腺纯小细胞神经内分泌癌患者因排尿困难入院1个月。直肠指检显示前列腺坚硬。组织学活检结果与前列腺小细胞神经内分泌癌的诊断一致。化疗与放疗联合方案被证明是有效的。病人的症状明显减轻。患者入院后约15个月死亡。前列腺小细胞神经内分泌癌预后极差。全身化疗是最重要的治疗方法。关键词：前列腺肿瘤；小细胞神经内分泌癌；化学疗法

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

A case report of small cell neuroendocrine carcinoma of prostate

To study the diagnosis and treatment of small cell neuroendocrine prostatic carcinoma. A 60-year-old patient with pure small cell neuroendocrine carcinoma of prostate was admitted because of dysuria for 1 month. Digital rectal examination showed the prostate was hard. Result of histological biopsy were consistent with a diagnosis of small cell neuroendocrine carcinoma of prostate. Combination chemotherapy with radiotherapy regimen were proved to be effective. The patient′s symptoms were relieved obviously. The patient died about 15 months after admission. Small cell neuroendocrine carcinoma of prostate has a very poor prognosis. Systemic chemotherapy is the most important treatment available. Key words: Prostatic neoplasms; Small cell neuroendocrine carcinoma; Chemotherapy

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

中华泌尿外科杂志 Medicine-Nephrology

CiteScore

0.10

自引率

0.00%

发文量

14180

期刊介绍： Chinese Journal of Urology (monthly) was founded in 1980. It is a publicly issued academic journal supervised by the China Association for Science and Technology and sponsored by the Chinese Medical Association. It mainly publishes original research papers, reviews and comments in this field. This journal mainly reports on the latest scientific research results and clinical diagnosis and treatment experience in the professional field of urology at home and abroad, as well as basic theoretical research results closely related to clinical practice. The journal has columns such as treatises, abstracts of treatises, experimental studies, case reports, experience exchanges, reviews, reviews, lectures, etc. Chinese Journal of Urology has been included in well-known databases such as Peking University Journal (Chinese Journal of Humanities and Social Sciences), CSCD Chinese Science Citation Database Source Journal (including extended version), and also included in American Chemical Abstracts (CA). The journal has been rated as a quality journal by the Association for Science and Technology and as an excellent journal by the Chinese Medical Association.